Starling Oncology (STLN) Revenue & Revenue Breakdown

Starling Oncology Revenue Highlights

Latest Revenue (Y)

$502.73M

Latest Revenue (Q)

$161.28M

Starling Oncology Revenue by Period

Starling Oncology Revenue by Year

Date	Revenue	Change
2025-12-31	$502.73M	-

Starling Oncology generated $502.73M in revenue during NA 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Starling Oncology Revenue by Quarter

Date	Revenue	Change
2026-06-30	$161.28M	9.39%
2026-03-31	$147.44M	3.86%
2025-12-31	$141.96M	3.95%
2025-09-30	$136.56M	-

Starling Oncology generated $161.28M in revenue during Q2 2026, up 9.39% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

STLN Revenue FAQ

What is Starling Oncology’s yearly revenue?

Starling Oncology's yearly revenue for 2025 was $502.73M, representing an increase of 0% compared to 2024.

What is Starling Oncology’s quarterly revenue?

Starling Oncology's quarterly revenue for Q2 2026 was $161.28M, a 9.39% increase from the previous quarter (Q1 2026). The company's quarterly revenue for Q1 2026 was $147.44M, a 3.86% increase from the previous quarter (Q4 2025). STLN's quarterly revenue for Q4 2025 was $141.96M, a 3.95% increase from the previous quarter (Q3 2025).